Innovations in Biotech and Healthcare Industry
Update: 2025-09-30
Description
NRx Pharmaceuticals re-files its application for a preservative-free IV ketamine formulation, while Fifty 1 Labs, Inc. signs a Letter of Intent to acquire BioSpark AI Technologies Inc. Lantern Pharma Inc. gears up for a clinical trial targeting a rare pediatric disease, and scientists discover the potential of scorpion venom in fighting brain cancer. Tonix Pharmaceuticals Holding Corp. advances its treatment for Prader-Willi Syndrome, and Soligenix Inc. expands its European Medical Advisory Board for a Phase 3 trial. Branded Legacy, Inc. files a patent application for an intranasal drug delivery device, and Doctorpresso introduces Therapods at CES 2026, revolutionizing mental healthcare.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
